Literature DB >> 11862376

Effects of repeated cortisol administration on brain potential correlates of episodic memory retrieval.

R H McAllister-Williams1, M D Rugg.   

Abstract

RATIONALE: Neuropsychological impairments in depressive illness may be secondary to hypercortisolaemia. Cortisol administration to healthy subjects impairs episodic memory, though how this is mediated is unknown.
OBJECTIVES: To examine the effects of 1 week's administration of cortisol on the neural correlates of episodic memory in healthy subjects.
METHODS: Fourteen healthy men were treated with oral cortisol (hydrocortisone 20 mg) or placebo twice daily for 1 week, in a double blind, crossover fashion. Event related potentials (ERPs) were recorded during a well-validated source memory task. Subjects listened to words spoken in a male or female voice. At test, old and new words were presented visually; subjects judged whether words were old or new, and if old, the gender of the voice at study.
RESULTS: Response times were significantly speeded by cortisol. A significant reduction in recognition accuracy with cortisol was found for the second study occasion. ERP recordings with placebo showed greater positivity over left parietal and right frontal scalp areas for ERPs to items given correct source judgements versus correctly rejected new items. In comparison, cortisol increased ERP voltage between 500 and 1400 ms post-stimulus and this effect interacted with item type and electrode site, being diffusely distributed for correct rejections but of a lesser magnitude frontally for old items accorded a correct source judgement.
CONCLUSIONS: Repeated cortisol administration leads to a qualitative change in the neural correlates of episodic memory retrieval in healthy subjects. This change may contribute to cognitive impairments seen in illnesses characterised by hypercortisolaemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11862376     DOI: 10.1007/s00213-001-0938-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis.

Authors:  M Aas; P Dazzan; V Mondelli; T Toulopoulou; A Reichenberg; M Di Forti; H L Fisher; R Handley; N Hepgul; T Marques; A Miorelli; H Taylor; M Russo; B Wiffen; A Papadopoulos; K J Aitchison; C Morgan; R M Murray; C M Pariante
Journal:  Psychol Med       Date:  2010-06-09       Impact factor: 7.723

2.  Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers.

Authors:  F C Hsu; M J Garside; A E Massey; R H McAllister-Williams
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

3.  Cortisol and memory retrieval in women: influence of menstrual cycle and oral contraceptives.

Authors:  Sabrina Kuhlmann; Oliver T Wolf
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

4.  Mild test anxiety influences neurocognitive performance among African Americans and European Americans: identifying interfering and facilitating sources.

Authors:  April D Thames; Stella E Panos; Alyssa Arentoft; Desiree A Byrd; Charles H Hinkin; Natalie Arbid
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2014-08-11

5.  Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders.

Authors:  Monica Aas; Srdjan Djurovic; Lavinia Athanasiu; Nils Eiel Steen; Ingrid Agartz; Steinar Lorentzen; Kjetil Sundet; Ole A Andreassen; Ingrid Melle
Journal:  Schizophr Bull       Date:  2011-09-09       Impact factor: 9.306

6.  Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study.

Authors:  Hamid A Alhaj; Anna E Massey; R Hamish McAllister-Williams
Journal:  Psychopharmacology (Berl)       Date:  2005-10-18       Impact factor: 4.530

7.  Endotoxemia-induced inflammation and the effect on the human brain.

Authors:  Mark van den Boogaard; Bart P Ramakers; Nens van Alfen; Sieberen P van der Werf; Wilhelmina F Fick; Cornelia W Hoedemaekers; Marcel M Verbeek; Lisette Schoonhoven; Johannes G van der Hoeven; Peter Pickkers
Journal:  Crit Care       Date:  2010-05-05       Impact factor: 9.097

8.  Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study).

Authors:  R Hamish McAllister-Williams; Eleanor Smith; Ian M Anderson; Jane Barnes; Peter Gallagher; Heinz C R Grunze; Peter M Haddad; Allan O House; Tom Hughes; Adrian J Lloyd; Elaine M M McColl; Simon H S Pearce; Najma Siddiqi; Baxi Sinha; Chris Speed; I Nick Steen; June Wainright; Stuart Watson; Fiona H Winter; I Nicol Ferrier
Journal:  BMC Psychiatry       Date:  2013-08-03       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.